Evidence map›Paper›PMID 37283223›Full record

ArticleBiology open2023

A monoclonal antibody raised against human EZH2 cross-reacts with the RNA-binding protein SAFB.

Rachel E Cherney, Christine A Mills, Laura E Herring, Aki K Braceros, J Mauro Calabrese

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rachel E CherneyDepartment of Pharmacology, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
Christine A MillsDepartment of Pharmacology, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
Laura E HerringDepartment of Pharmacology, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
Aki K BracerosDepartment of Pharmacology, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
J Mauro CalabreseDepartment of Pharmacology, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.ORCID 0000-0002-1213-2540
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Cooperative control of Polycomb Repressive Complexes by long noncoding RNAs, CpG island DNA, and RNA-binding proteinsR01GM136819 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CALABRESE, JOSEPH MAURO · 2020 to 2023
$1.5M
Training in Mechanistic, Interdisciplinary Studies of Biological SystemsT32GM119999 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RAMSDEN, DALE A · 2017 to 2021
$1.2M
Control of gene silencing by long noncoding RNAs in trophoblast stem cellsF31HD103370 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BRACEROS, AKI KEEAN · 2020 to 2022
$114k
Regulation of Polycomb by long noncoding RNAs during pre-implantation developmentF31HD103334 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHERNEY, RACHEL ELIZABETH · 2020 to 2022
$113k
NCI NIH HHS P30 CA016086NICHD NIH HHS F31 HD103334NICHD NIH HHS F31 HD103370NIGMS NIH HHS R01 GM136819NIGMS NIH HHS T32 GM007092NIGMS NIH HHS T32 GM119999
6 · The paper itself

Abstract

The Polycomb Repressive Complex 2 (PRC2) is a conserved enzyme that tri-methylates Lysine 27 on Histone 3 (H3K27me3) to promote gene silencing. PRC2 is remarkably responsive to the expression of certain long noncoding RNAs (lncRNAs). In the most notable example, PRC2 is recruited to the X-chromosome shortly after expression of the lncRNA Xist begins during X-chromosome inactivation. However, the mechanisms by which lncRNAs recruit PRC2 to chromatin are not yet clear. We report that a broadly used rabbit monoclonal antibody raised against human EZH2, a catalytic subunit of PRC2, cross-reacts with an RNA-binding protein called Scaffold Attachment Factor B (SAFB) in mouse embryonic stem cells (ESCs) under buffer conditions that are commonly used for chromatin immunoprecipitation (ChIP). Knockout of EZH2 in ESCs demonstrated that the antibody is specific for EZH2 by western blot (no cross-reactivity). Likewise, comparison to previously published datasets confirmed that the antibody recovers PRC2-bound sites by ChIP-Seq. However, RNA-IP from formaldehyde-crosslinked ESCs using ChIP wash conditions recovers distinct peaks of RNA association that co-localize with peaks of SAFB and whose enrichment disappears upon knockout of SAFB but not EZH2. IP and mass spectrometry-based proteomics in wild-type and EZH2 knockout ESCs confirm that the EZH2 antibody recovers SAFB in an EZH2-independent manner. Our data highlight the importance of orthogonal assays when studying interactions between chromatin-modifying enzymes and RNA.

Indexed as

Matrix Attachment Region Binding ProteinsRNA, Long NoncodingAnimalsAntibodies, MonoclonalChromatinEnhancer of Zeste Homolog 2 ProteinHumansMiceMice, KnockoutNuclear Matrix-Associated ProteinsPolycomb Repressive Complex 2Receptors, EstrogenRNA-Binding ProteinsAntibodies, MonoclonalChromatinEnhancer of Zeste Homolog 2 ProteinMatrix Attachment Region Binding ProteinsNuclear Matrix-Associated ProteinsPolycomb Repressive Complex 2Receptors, EstrogenRNA-Binding ProteinsRNA, Long NoncodingSAFB protein, humanEZH2LncRNAPolycombPRC2SAFBXist

Identifiers

PMID37283223
PMCPMC10259849
OpenAlexW4379600073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.